Table of Contents

7 YEARS OF ADVANCING NORDIC BIOPHARMA.

From Innovation to Industrial Impact.

18 - 19 March 2026 | Stockholm, Sweden

Table of Contents

7 YEARS OF ADVANCING NORDIC BIOPHARMA.

From Innovation to Industrial Impact.

18 - 19 March 2026 | Stockholm, Sweden

Now in its 7th year, this is the Nordic region’s leading summit dedicated to bridging biologics R&D with scalable GMP manufacturing – uniting science, digital innovation, and commercial scale-up across the region.

ATTENDING COMPANIES INCLUDE

pariatur aliqua

Anim excepteur cillum irure reprehenderit non. Pariatur adipisicing labore ut mollit. Veniam officia veniam.

pariatur aliqua

Anim excepteur cillum irure reprehenderit non. Pariatur adipisicing labore ut mollit. Veniam officia veniam.

pariatur aliqua

Anim excepteur cillum irure reprehenderit non. Pariatur adipisicing labore ut mollit. Veniam officia veniam.

pariatur aliqua

Anim excepteur cillum irure reprehenderit non. Pariatur adipisicing labore ut mollit. Veniam officia veniam.

pariatur aliqua

Anim excepteur cillum irure reprehenderit non. Pariatur adipisicing labore ut mollit. Veniam officia veniam.

pariatur aliqua

Anim excepteur cillum irure reprehenderit non. Pariatur adipisicing labore ut mollit. Veniam officia veniam.

pariatur aliqua

Anim excepteur cillum irure reprehenderit non. Pariatur adipisicing labore ut mollit. Veniam officia veniam.

pariatur aliqua

Anim excepteur cillum irure reprehenderit non. Pariatur adipisicing labore ut mollit. Veniam officia veniam.

pariatur aliqua

Anim excepteur cillum irure reprehenderit non. Pariatur adipisicing labore ut mollit. Veniam officia veniam.

pariatur aliqua

Anim excepteur cillum irure reprehenderit non. Pariatur adipisicing labore ut mollit. Veniam officia veniam.

pariatur aliqua

Anim excepteur cillum irure reprehenderit non. Pariatur adipisicing labore ut mollit. Veniam officia veniam.

pariatur aliqua

Anim excepteur cillum irure reprehenderit non. Pariatur adipisicing labore ut mollit. Veniam officia veniam.

pariatur aliqua

Anim excepteur cillum irure reprehenderit non. Pariatur adipisicing labore ut mollit. Veniam officia veniam.

pariatur aliqua

Anim excepteur cillum irure reprehenderit non. Pariatur adipisicing labore ut mollit. Veniam officia veniam.

pariatur aliqua

Anim excepteur cillum irure reprehenderit non. Pariatur adipisicing labore ut mollit. Veniam officia veniam.

pariatur aliqua

Anim excepteur cillum irure reprehenderit non. Pariatur adipisicing labore ut mollit. Veniam officia veniam.

pariatur aliqua

Anim excepteur cillum irure reprehenderit non. Pariatur adipisicing labore ut mollit. Veniam officia veniam.

pariatur aliqua

Anim excepteur cillum irure reprehenderit non. Pariatur adipisicing labore ut mollit. Veniam officia veniam.

pariatur aliqua

Anim excepteur cillum irure reprehenderit non. Pariatur adipisicing labore ut mollit. Veniam officia veniam.

pariatur aliqua

Anim excepteur cillum irure reprehenderit non. Pariatur adipisicing labore ut mollit. Veniam officia veniam.

pariatur aliqua

Anim excepteur cillum irure reprehenderit non. Pariatur adipisicing labore ut mollit. Veniam officia veniam.

pariatur aliqua

Anim excepteur cillum irure reprehenderit non. Pariatur adipisicing labore ut mollit. Veniam officia veniam.

pariatur aliqua

Anim excepteur cillum irure reprehenderit non. Pariatur adipisicing labore ut mollit. Veniam officia veniam.

pariatur aliqua

Anim excepteur cillum irure reprehenderit non. Pariatur adipisicing labore ut mollit. Veniam officia veniam.

BUILT FOR THE NORDICS

Focused on the region’s core strengths in biologics R&D, process excellence, and smart manufacturing - linking academic, clinical, and commercial stakeholders to drive the full lifecycle from discovery to commercialisation.

WHO

For biopharma and big pharma leaders across the Nordics - from R&D, MSAT, and manufacturing to digital, quality, and strategic teams who are advancing the next generation of biologics. This summit unites R&D, clinical development, Quality Assurance (QA), Manufacturing Science and Technology (MSAT), and manufacturing functions from leading pharmaceutical companies and emerging biotechs.

WHAT

A strategic platform designed to bridge the Nordics' strong biologics R&D capabilities with scalable GMP manufacturing. The summit features two concurrent tracks:

R&D & Clinical Trials and Biologics Manufacturing - offering targeted insights across the full development and production spectrum.

Key themes driving every session include:

  • R&D Innovation & Clinical-to-GMP Translation
  • Biologics Manufacturing & Scale-Up
  • Digitalisation, Automation & Quality
  • Strategic & Public-Private Partnerships

Built around the Nordics’ strengths, the event connects academic, clinical, and commercial stakeholders to drive the full lifecycle of biologics from discovery to commercialisation.

WHY

To enable end-to-end collaboration by uniting R&D, clinical development, and manufacturing functions across the entire biologics value chain. The summit aligns these functions through shared challenges, practical insight, and country-specific case studies.

Whether you are focused on achieving scalable production , developing regional infrastructure , or integrating digital technologies like AI and GMP 4.0 , this is where Nordic science meets global strategy.

KEY THEMES & TOPICS

R&D Innovation & Clinical-to-GMP Translation

Delve into breakthroughs in monoclonal antibodies, bispecifics, and RNA-based therapeutics, and navigate the critical transition from preclinical development to GMP-compliant production.

Biologics Manufacturing & Scale-Up

Explore strategies for optimising manufacturing processes, achieving scalable production, and enhancing efficiency through intensified bioprocessing, modular facilities, and single-use technologies.

Digitalisation, Automation & Quality

Discover how digital twins, AI, and advanced process control are enhancing data integrity, compliance, and efficiency across the biomanufacturing lifecycle under GMP 4.0 principles.

Strategic & Public-Private Partnerships

Gain insights on fostering impactful collaborations between industry, academia, and government to build a robust Nordic biologics ecosystem and accelerate innovation.

300+

Senior attendees across biologics manufacturing, biosimilars development, quality, tech ops, regulatory affairs, and strategic partnerships.

50+

Expert speakers shaping the future of biologics and next-generation therapeutics in the Nordics – from early discovery through to commercialisation.

100+

Companies represented, including leading Nordic biotechs, multinational pharmas, pioneering CDMOs, regulators, and academic collaborators.

1 Dedicated Track

Insightful content streams across R&D & Clinical Trials and Biologics Manufacturing – tailored to Nordic innovation and production excellence.

Strategic Roundtables & Panels

Deep dives into digital transformation , R&D-to-manufacturing alignment , public-private partnerships, and the future of the biomanufacturing workforce.

Hosted in Stockholm

A dynamic hub for biotech innovation and international life sciences investment – at the heart of the Nordic region.

Get Your Ticket
View the 2025 Post-Event Report